Association of Cholinergic Muscarinic M4 Receptor Gene Polymorphism with Schizophrenia

Association of Cholinergic Muscarinic M4 Receptor Gene Polymorphism with Schizophrenia

Ivan V Pozhidaev,1,2 Anastasiia S Boiko,1 Anton JM Loonen,3 Diana Z Paderina,1,2 Olga Yu Fedorenko,1,4 Gennadiy Tenin,5 Elena G Kornetova,1,6 Arkadiy V Semke,1 Nikolay A Bokhan,1,2,6 Bob Wilffert,3,7 Svetlana A Ivanova1,4,6 1Mental Health Research Institute, Tomsk National Research Medical Center of...

Full description

Bibliographic Details
Main Authors:	Pozhidaev IV, Boiko AS, Loonen AJM, Paderina DZ, Fedorenko OY, Tenin G, Kornetova EG, Semke AV, Bokhan NA, Wilffert B, Ivanova SA
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-04-01
Series:	The Application of Clinical Genetics
Subjects:	schizophrenia suicide tardive dyskinesia pacsin3 chrm4 gene polymorphism
Online Access:	https://www.dovepress.com/association-of-cholinergic-muscarinic-m4-receptor-gene-polymorphism-wi-peer-reviewed-article-TACG

Similar Items

5-Hydroxytryptamine Receptors and Tardive Dyskinesia in Schizophrenia
by: Ivan V. Pozhidaev, et al.
Published: (2020-04-01)

Genes of the Glutamatergic System and Tardive Dyskinesia in Patients with Schizophrenia
by: Olga Yu. Fedorenko, et al.
Published: (2022-06-01)

Search for Possible Associations of FTO Gene Polymorphic Variants with Metabolic Syndrome, Obesity and Body Mass Index in Schizophrenia Patients
by: Boiko AS, et al.
Published: (2021-09-01)

Association between genetic variants of the cholinergic system and postoperative delirium and cognitive dysfunction in elderly patients
by: Maria Heinrich, et al.
Published: (2021-10-01)

An investigation on the relationship between risk factors and severity of tardive dyskinesia
by: Y Kalafi, et al.
Published: (1993-12-01)

Risperidone induced tardive movements in an elderly male-a case of cognitive decline masked by behavioral abnormalities
by: Vishnupriya Veeraraghavan, et al.
Published: (2022-12-01)

Tardive dyskinesia on clozapine: A case report
by: Laila Asmal
Published: (2009-03-01)

Tardive dyskinesia in an 8-year old child
by: W. M.M.L. Chandradasa, et al.
Published: (2014-12-01)

Successful Treatment of Tardive Diaphragmatic Flutter in an Elderly Man with Aripiprazole
by: Yi-Hsiang Chen, et al.
Published: (2013-06-01)

Drug-induced tardive dyskinesia
by: T. M. Ostroumova, et al.
Published: (2020-02-01)

Relationship between physical exercise and the most varied forms of dyskinesia
by: Ana Elisa Speck, et al.
Published: (2021-04-01)

Probable respiratory dyskinesia in an elderly patient after sudden stoppage of antipsychotics
by: Vikram Vaidya, et al.
Published: (2016-01-01)

Scopolamine alleviates involuntary lingual movements: tardive dyskinesia or dystonia?
by: Hu JB, et al.
Published: (2017-08-01)

Abdominal Wall Dyskinesia: Case Report
by: Leyla Cavdar, et al.
Published: (2020-02-01)

Tardive Dyskinesia in Older Persons Taking Antipsychotics
by: Citrome L, et al.
Published: (2021-10-01)

Olanzapine induced tardive dyskinesia
by: Rudraprosad Chakraborty, et al.
Published: (2014-01-01)

Drug-Induced Movement Disorders and Its Associated Factors Among Patients Attending Treatment at Public Hospitals in Eastern Ethiopia
by: Misgana T, et al.
Published: (2020-08-01)

Tardive Dyskinesia and Treatment Approaches
by: Mehmet Emin Demirkol, et al.
Published: (2018-06-01)

Metoclopramide in Gastroparesis: Its Mechanism of Action and Safety Profile
by: M Ammar Kalas, et al.
Published: (2023-08-01)

Facial mask masking tardive dyskinesia
by: I. Ganhao
Published: (2021-04-01)

Extrapyramidal side effects in first-episode schizophrenia treated with flupenthixol decanoate
by: Francois-Pierre Joubert, et al.
Published: (2021-01-01)

Early onset tardive syndromes associated with Lurasidone in patients with mood disorders: A case series and literature review
by: Aditya Nidumolu, et al.
Published: (2022-12-01)

Reliability and clinical utility of a Portuguese version of the Abnormal Involuntary Movements Scale (AIMS) for tardive dyskinesia in Brazilian patients
by: H. Tonelli, et al.
Published: (2003-04-01)

Case report: Pallidal deep brain stimulation for treatment of tardive dystonia/dyskinesia secondary to chronic metoclopramide medication
by: Johanna M. Nagel, et al.
Published: (2023-01-01)

Putative role of immune reactions in the mechanism of tardive dyskinesia
by: Anton J.M. Loonen
Published: (2023-11-01)

Tardive dyskinesia: Prevention and newer management strategies
by: Sreelakshmi Vaidyanathan, et al.
Published: (2020-01-01)

Drug induced movement disorders /
by: Factor, Stewart A., 1956-, et al.
Published: (2005)

How to conquer tardive dyskinesia: could pharmacogenetics and therapy drug monitoring be useful tools?
by: Dino Žujić, et al.
Published: (2023-01-01)

The Tardive Dyskinesia Impact Scale (TDIS), a novel patient-reported outcome measure in tardive dyskinesia: development and psychometric validation
by: Robert H. Farber, et al.
Published: (2024-01-01)

A descriptive analysis of spontaneous reports of antipsychotic‐induced tardive dyskinesia and other extrapyramidal symptoms in the Japanese Adverse Drug Event Report database
by: Yosuke Saga, et al.
Published: (2024-03-01)

Bacillus Calmette–Guérin Vaccine Attenuates Haloperidol-Induced TD-like Behavioral and Neurochemical Alteration in Experimental Rats
by: Narhari Gangaram Yedke, et al.
Published: (2023-11-01)

Deep Brain Stimulation in the Treatment of Tardive Dyskinesia
by: Adrianna Szczakowska, et al.
Published: (2023-02-01)

Historical developments, hotspots, and trends in tardive dyskinesia research: a scientometric analysis of 54 years of publications
by: Anuradha Baminiwatta, et al.
Published: (2023-06-01)

Treatment of tardive dyskinesia with VMAT-2 inhibitors: a systematic review and meta-analysis of randomized controlled trials
by: Solmi M, et al.
Published: (2018-05-01)

Variations of Aripiprazole-Induced Dyskinesia Existing with Concurrent Use of Amantadine and an Anticholinergic Agent in an Elderly Patient
by: I-Wen Sun, et al.
Published: (2012-06-01)

Lurasidone-induced tardive dyskinesia
by: Shreyas Shrikant Pendharkar, et al.
Published: (2022-01-01)

Psychotropic Medications-Induced Tardive Dyskinesia and Associated Factors Among Patients with Mental Illness in Ethiopia
by: Kumsa A, et al.
Published: (2020-12-01)

Severe tardive dystonia on low dose short duration exposure to atypical antipsychotics: Factors explored
by: Nilanjan C Chandra, et al.
Published: (2017-01-01)

Cortisol and DHEAS Related to Metabolic Syndrome in Patients with Schizophrenia
by: Boiko AS, et al.
Published: (2020-04-01)

Bridging the gap between statistical significance and clinical relevance: A systematic review of minimum clinically important difference (MCID) thresholds of scales reported in movement disorders research
by: Biswamohan Mishra, et al.
Published: (2024-03-01)